Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients-A Systematic Review
This systematic review examines the available clinical data on CD34+ cell mobilization, collection, and engraftment in multiple myeloma patients treated with the anti-CD38 monoclonal antibodies daratumumab and isatuximab in clinical trials and in real life. Twenty-six clinical reports were published...
Saved in:
Main Authors: | Flavia Bigi (Author), Enrica Manzato (Author), Simona Barbato (Author), Marco Talarico (Author), Michele Puppi (Author), Simone Masci (Author), Ilaria Sacchetti (Author), Roberta Restuccia (Author), Miriam Iezza (Author), Ilaria Rizzello (Author), Chiara Sartor (Author), Katia Mancuso (Author), Lucia Pantani (Author), Paola Tacchetti (Author), Michele Cavo (Author), Elena Zamagni (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Monoclonal Antibodies in Smoldering and Newly Diagnosed Transplant-Eligible Multiple Myeloma
by: Elena Zamagni, et al.
Published: (2020) -
Reactivation of HIV-1 proviruses in immune-compromised mice engrafted with human VOA-negative CD4+ T cells
by: Zhe Yuan, et al.
Published: (2017) -
NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment
by: Antonio Pierini, et al.
Published: (2016) -
Anti CD38 monoclonal antibodies for multiple myeloma treatment
by: Alessandro Gozzetti, et al.
Published: (2022) -
Reactivation of VOA-inducible and -uninducible HIV-1 proviruses using immune-compromised mice engrafted with human resting CD4+ T cells
by: Z. Yuan, et al.
Published: (2015)